Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision update applied: v3.4.3 replacing the previous v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a general funding-status notice at the top of the page. Updated the page to version 3.4.1 and removed the 3.4.0 reference.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now includes a glossary toggle and new metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with 'No FEAR Act Data' and a revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no user-visible changes to the Study Details page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section listing study sites in Arizona, California, Florida, Ohio, Tennessee, and Texas; updated revision to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.